Oruka Therapeutics, Inc.
ORKA
Classifica tra le azioni
#3267
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Prezzo delle azioni
$80.46
Capitalizzazione di mercato
$5.33B
Variazione (1 giorno)
0.67%
Variazione (1 anno)
201.90%
Paese
US
Scambia Oruka Therapeutics, Inc. (ORKA)
Categoria
Healthcare
Rapporto P/S per Oruka Therapeutics, Inc. (ORKA)
Rapporto P/S al October 2026 TTM: 0.00
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Oruka Therapeutics, Inc., il rapporto P/S attuale (TTM) è 0.00. Alla fine del 2024, era pari a 0.00.
Storico del rapporto P/S per Oruka Therapeutics, Inc. da 2005 a 2026
Rapporto P/S alla fine di ogni anno
| Anno | Rapporto P/S | Cambia |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | 0.00% |
| 2022 | 0.00 | 0.00% |
| 2021 | 0.00 | 0.00% |
| 2020 | 0.00 | 0.00% |
| 2019 | 0.00 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
| 2016 | 0.00 | 0.00% |
| 2015 | 0.00 | 0.00% |
| 2014 | 0.00 | 0.00% |
| 2013 | 0.00 | 0.00% |
| 2012 | 0.00 | 0.00% |
| 2011 | 0.00 | 0.00% |
| 2010 | 0.00 | 0.00% |
| 2009 | 0.00 | 0.00% |
| 2008 | 0.00 | -100.00% |
| 2007 | 2.08 | -96.07% |
| 2006 | 52.93 | -91.38% |
| 2005 | 614.26 | 0.00% |
Rapporto P/S per aziende simili o concorrenti
| Azienda | Rapporto P/S | Differenza del rapporto P/S | Il paese |
|---|---|---|---|
| 10.72 | - |
US
|
|
| 41.70 | - |
US
|
|
| 4.19 | - |
AU
|
|
| 5.80 | - |
BE
|
|
| 10.44 | - |
NL
|
